Hurun India Rich List 2026 edition · 1 director
- #1,009 Gautam Daftary & family ₹2,700 Cr
Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Active Private Limited Company pharma
Revenue · FY 2025
₹34,420
▼ 33.33% YoY
Net loss · FY 2025
₹3.31 Cr
Latest filing
EBITDA · FY 2025
-₹3.31 Cr
Latest filing
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.02 Lakh
Issued & subscribed
Company age
31 yrs
Est. 1995
Employees · EPFO
2
Provident fund records
Directors on board
2
As per MCA filings
About Aksigen Pharmaceuticals Private Limited
Data last updated:
Aksigen Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 August 1995 and has been in existence for over 31 years.
Its director Gautam Daftary and family are #1,009 on the Hurun India Rich List 2026.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1995PTC091631. Its GSTIN is 27AADCA9664J1Z8 (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.02 Lakh. It was formerly known as Aksign Finvest Private Limited. It is led by directors Siddharth Bharat Daftary and Gautam Vinod Daftary.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17th Floor Hoechst House Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹34,420. For the same year it recorded a net loss of ₹3.31 Cr and EBITDA of -₹3.31 Cr. Revenue has declined at a compounded annual rate (CAGR) of 65% over three years and 30% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Aksigen Pharmaceuticals Private Limited
CIN U24239MH1995PTC091631
Registration Number 091631
Incorporation Date 09 August 1995
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Recognitions & Rankings of Aksigen Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address17th Floor Hoechst House Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Aksigen Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Aksigen Pharmaceuticals Private Limited FY 2025 filings available
Aksigen Pharmaceuticals Private Limited reported revenue of ₹34,420 for FY 2025.
Revenue · FY 2025
₹34,420
Net loss · FY 2025
₹3.31 Cr
EBITDA · FY 2025
-₹3.31 Cr
Compounded Annual Growth Rate (CAGR) of Aksigen Pharmaceuticals Private Limited
Revenue CAGR growth
3 years · compounded
▼ 65%
5 years · compounded
▼ 30%
EBITDA CAGR growth
1 year
▼ 143%
3 years · compounded
▼ 103%
5 years · compounded
▼ 94%
Revenue has declined at a compounded annual rate (CAGR) of 30% over five years. EBITDA fell 143% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Aksigen Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.31 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.31 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Aksigen Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Aksigen Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddharth Bharat Daftary Also directs: Hitech Laboratories Private Limited, Genei Laboratories Private Limited, Rivaara Labs Private Limited and 5 more | Director | 07 Dec 2023 | 2 Years 10 Months | Current |
| Gautam Vinod Daftary Also directs: Iravata Retail Enterprises LLP, Palettier Retail Private Limited, Hitech Laboratories Private Limited and 5 more | Director | 09 Aug 2005 | 21 Years 2 Months | Current |
Peer Comparison of Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Beatus Pharmaceuticals Private Limited | ₹34,982 (FY 2025) | •••• | •••• | 19.0% | •••• | Lucknow, Uttar Pradesh, India |
| Kedia House of Medicines Limited | ₹34,957 (FY 2019) | •••• | •••• | -97.0% | •••• | Gurgaon, Haryana, India |
| Aarna Pharmaceuticals Private Limited | ₹34,780 (FY 2025) | •••• | •••• | -64.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| MPDB Pharmaceuticals Private Limited | ₹34,545 (FY 2022) | •••• | •••• | -85.0% | •••• | Moradabad, Uttar Pradesh, India |
| C-Cayr Pharmaceuticals Private Limited | ₹34,456 (FY 2024) | •••• | •••• | -83.0% | •••• | Hyderabad, Telangana, India |
| Aksigen Pharmaceuticals Private Limited this company | ₹34,420 (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Zingbera Pharmaceuticals Private Limited | ₹34,418 (FY 2021) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Single Dose Pharmaceuticals Private Limited | ₹34,117 (FY 2023) | •••• | •••• | •••• | Aurangabad, Maharashtra, India | |
| Abide Health Care Private Limited | ₹34,116 (FY 2024) | •••• | •••• | 191.0% | •••• | Kolkata, West Bengal, India |
| Reno Chemicals Pharmaceuticals and Cosmetics Private Limited | ₹34,000 (FY 2021) | •••• | •••• | 1600.0% | •••• | Mumbai, Maharashtra, India |
| Sayone Pharmaceuticals Private Limited | ₹33,945 (FY 2022) | •••• | •••• | 3068.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Aksigen Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals Private Limited is audited by Vinay Sanjay & Associates for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Vinay Sanjay & Associates | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Aksigen Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals Private Limited has a workforce of 2 employees as of Apr 06, 2024.
Employee count
2
Active EPFO establishments
1
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Siddharth Bharat Daftary ceased to be Additional Director on 29 Sep 2024.
AGM
Aksigen Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aksigen Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Siddharth Bharat Daftary ceased to be Additional Director.
Ceased
Bharat Vinod Daftary ceased to be Director.
Appointed
Siddharth Bharat Daftary was appointed as Director.
Appointed
Gautam Vinod Daftary was appointed as Director.
Incorporation
09 Aug 1995
Aksigen Pharmaceuticals Private Limited was registered on 09 Aug 1995 with Roc Mumbai I & aged 31 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Aksigen Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Aksigen Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Aksigen Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCA9664J1Z8 | Maharashtra | Active | 29 Apr 2023 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Aksigen Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aksigen Pharmaceuticals Private Limited
Aksigen Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 August 1995 (31+ years old) and is registered under CIN U24239MH1995PTC091631.
Aksigen Pharmaceuticals reported revenue of ₹34,420 for FY 2025.
Aksigen Pharmaceuticals has 2 current directors:
- Siddharth Bharat Daftary - Director
- Gautam Vinod Daftary - Director
Aksigen Pharmaceuticals reported a net loss of ₹3.31 Cr and EBITDA of -₹3.31 Cr for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Aksigen Pharmaceuticals is -65% over three years and -30% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Aksigen Pharmaceuticals is 27AADCA9664J1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Aksigen Pharmaceuticals is U24239MH1995PTC091631. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aksigen Pharmaceuticals was incorporated on 09 August 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aksigen Pharmaceuticals by revenue are Beatus Pharmaceuticals Private Limited, Kedia House of Medicines Limited, Aarna Pharmaceuticals Private Limited, MPDB Pharmaceuticals Private Limited, C-Cayr Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Siddharth Bharat Daftary ceased to be Additional Director on 29 Sep 2024. Bharat Vinod Daftary ceased to be Director on 07 Dec 2023. Siddharth Bharat Daftary was appointed as Director on 07 Dec 2023. Aksigen Pharmaceuticals has 4 board changes on record in total.
The registered office of Aksigen Pharmaceuticals is at 17th Floor Hoechst House Nariman Point, Mumbai, Maharashtra, India – 400021.